UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 72

Sortiert nach

TMPRSS4 Drives Angiogenesis in Hepatocellular Carcinoma by Promoting HB‐EGF Expression and Proteolytic Cleavage

Hepatology (Baltimore, Md.), 2020-09, Vol.72 (3), p.923-939

2020

Volltextzugriff (PDF)

Role of hepatitis B core‐related antigen in predicting the occurrence and recurrence of hepatocellular carcinoma in patients with chronic hepatitis B: A systemic review and meta‐analysis

Journal of gastroenterology and hepatology, 2024-08, Vol.39 (8), p.1464-1475

2024

Volltextzugriff (PDF)

Enantioselective remote methylene C-H (hetero)arylation of cycloalkane carboxylic acids

Science (American Association for the Advancement of Science), 2024-05, Vol.384 (6697), p.793-798

2024

Volltextzugriff (PDF)

Regional and sex differences in the mortality risk associated with primary liver cancer in obesity: A systematic review and meta-analysis

Nutrition (Burbank, Los Angeles County, Calif.), 2023-09, Vol.113, p.112097-112097, Article 112097

2023

Volltextzugriff (PDF)

Effects of hypoxia‐inducible factor‐1α and hypoxia‐inducible factor‐2α overexpression on hepatocellular carcinoma survival: A systematic review with meta‐analysis

Journal of gastroenterology and hepatology, 2021-06, Vol.36 (6), p.1487-1496

2021

Volltextzugriff (PDF)

Peripheral cytokine levels as novel predictors of survival in cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis

Frontiers in immunology, 2022-08, Vol.13, p.884592-884592

2022

Volltextzugriff (PDF)

MALAT1/ mir-1-3p mediated BRF2 expression promotes HCC progression via inhibiting the LKB1/AMPK signaling pathway

Cancer cell international, 2023-08, Vol.23 (1), p.1-16, Article 188

2023

Volltextzugriff (PDF)

The Association of Glycemic Index, Glycemic Load, and Daily Carbohydrates Intake with the Risk of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis

Nutrition and cancer, 2023, Vol.75 (2), p.461-469

2023

Volltextzugriff (PDF)

The Predictive Potential of the Baseline C-Reactive Protein Levels for the Efficiency of Immune Checkpoint Inhibitors in Cancer Patients: A Systematic Review and Meta-Analysis

Frontiers in immunology, 2022-02, Vol.13, p.827788-827788

2022

Volltextzugriff (PDF)

Diacylglycerol lipase alpha promotes hepatocellular carcinoma progression and induces lenvatinib resistance by enhancing YAP activity

Cell death & disease, 2023-07, Vol.14 (7), p.404-404, Article 404

2023

Volltextzugriff (PDF)

Correction: MALAT1/ mir-1-3p mediated BRF2 expression promotes HCC progression via inhibiting the LKB1/AMPK signaling pathway

Cancer cell international, 2024-07, Vol.24 (1), p.1-3, Article 260

2024

Volltextzugriff (PDF)

Adverse events of immune checkpoint inhibitors in hepatocellular carcinoma: a systemic review and meta-analysis

Clinical and experimental medicine, 2023-10, Vol.23 (6), p.2115-2129

2023

Volltextzugriff (PDF)

The Prognostic Value of Natural Killer Cells and Their Receptors/Ligands in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis

Frontiers in immunology, 2022-04, Vol.13, p.872353-872353

2022

Volltextzugriff (PDF)

Clinical Benefit of Antiviral Agents for Hepatocellular Carcinoma Patients With Low Preoperative HBV-DNA Loads Undergoing Curative Resection: A Meta-Analysis

Frontiers in oncology, 2021-02, Vol.11, p.605648-605648

2021

Volltextzugriff (PDF)

A novel prognostic scoring model based on copper homeostasis and cuproptosis which indicates changes in tumor microenvironment and affects treatment response

Frontiers in pharmacology, 2023-02, Vol.14, p.1101749-1101749

2023

Volltextzugriff (PDF)

Somatic mutation and expression of BAP1 in hepatocellular carcinoma: an indicator for ferroptosis and immune checkpoint inhibitor therapies

Journal of Cancer, 2022, Vol.13 (1), p.88-101

2022

Volltextzugriff (PDF)

A model based on adipose and muscle-related indicators evaluated by CT images for predicting microvascular invasion in HCC patients

Biomarker research, 2023-10, Vol.11 (1), p.1-87, Article 87

2023

Volltextzugriff (PDF)

Correction to: Hepatic metastatic paraganglioma 12 years after retroperitoneal paraganglioma resection: a case report

BMC gastroenterology, 2019-08, Vol.19 (1), p.152-152, Article 152

2019

Volltextzugriff (PDF)

Response to Letter Entitled “Re: Anthropometric indicators of adiposity and risk of primary liver cancer: a systematic review and dose-response meta-analysis”

European journal of cancer (1990), 2023-10, Vol.192, p.113257-113257, Article 113257

2023

Volltextzugriff (PDF)

Sex and regional disparities in incidence of hepatocellular carcinoma in autoimmune hepatitis: a systematic review and meta-analysis

Hepatology international, 2021-12, Vol.15 (6), p.1413-1420

2021

Volltextzugriff (PDF)

Hepatic metastatic paraganglioma 12 years after retroperitoneal paraganglioma resection: a case report

BMC gastroenterology, 2019-08, Vol.19 (1), p.142-142, Article 142

2019

Volltextzugriff (PDF)

RECK expression is associated with angiogenesis and immunogenic Tumor Microenvironment in Hepatocellular Carcinoma, and is a prognostic factor for better survival

Journal of Cancer, 2021-01, Vol.12 (13), p.3827-3840

2021

Volltextzugriff (PDF)

The somatic mutational landscape and role of the ARID1A gene in hepatocellular carcinoma

Heliyon, 2023-03, Vol.9 (3), p.e14307-e14307, Article e14307

2023

Volltextzugriff (PDF)

Anthropometric indicators of adiposity and risk of primary liver cancer: A systematic review and dose–response meta-analysis

European journal of cancer (1990), 2023-05, Vol.185, p.150-163

2023

Volltextzugriff (PDF)

Hepatitis B virus reactivation in patients undergoing immune checkpoint inhibition: systematic review with meta-analysis

Journal of cancer research and clinical oncology, 2023-05, Vol.149 (5), p.1993-2008

2023

Volltextzugriff (PDF)

1 – 25 von 72

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(65)
Mit Volltextzugriff
(63)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(53)
Life Sciences & Biomedicine
(43)
Hepatocellular Carcinoma
(24)
Humans
(22)
Meta-Analysis
(18)
Prognosis
(16)
Liver Cancer
(15)
Oncology
(15)
Gastroenterology & Hepatology
(12)
Chemistry
(9)
Immune Checkpoint Inhibitors
(9)
Physical Sciences
(9)
Immunology
(8)
Cancer
(7)
Carcinoma, Hepatocellular - Pathology
(6)
Liver Neoplasms - Pathology
(6)
Medical Prognosis
(6)
Medicine
(6)
Medicine & Public Health
(6)
Tumors
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

TMPRSS4 Drives Angiogenesis in Hepatocellular Carcinoma by Promoting HB‐EGF Expression and Proteolytic Cleavage

Role of hepatitis B core‐related antigen in predicting the occurrence and recurrence of hepatocellular carcinoma in patients with chronic hepatitis B: A systemic review and meta‐analysis

Enantioselective remote methylene C-H (hetero)arylation of cycloalkane carboxylic acids

Regional and sex differences in the mortality risk associated with primary liver cancer in obesity: A systematic review and meta-analysis

Effects of hypoxia‐inducible factor‐1α and hypoxia‐inducible factor‐2α overexpression on hepatocellular carcinoma survival: A systematic review with meta‐analysis

Peripheral cytokine levels as novel predictors of survival in cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis

MALAT1/ mir-1-3p mediated BRF2 expression promotes HCC progression via inhibiting the LKB1/AMPK signaling pathway

The Association of Glycemic Index, Glycemic Load, and Daily Carbohydrates Intake with the Risk of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis

The Predictive Potential of the Baseline C-Reactive Protein Levels for the Efficiency of Immune Checkpoint Inhibitors in Cancer Patients: A Systematic Review and Meta-Analysis

Diacylglycerol lipase alpha promotes hepatocellular carcinoma progression and induces lenvatinib resistance by enhancing YAP activity

Correction: MALAT1/ mir-1-3p mediated BRF2 expression promotes HCC progression via inhibiting the LKB1/AMPK signaling pathway

Adverse events of immune checkpoint inhibitors in hepatocellular carcinoma: a systemic review and meta-analysis

The Prognostic Value of Natural Killer Cells and Their Receptors/Ligands in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis

Clinical Benefit of Antiviral Agents for Hepatocellular Carcinoma Patients With Low Preoperative HBV-DNA Loads Undergoing Curative Resection: A Meta-Analysis

A novel prognostic scoring model based on copper homeostasis and cuproptosis which indicates changes in tumor microenvironment and affects treatment response

Somatic mutation and expression of BAP1 in hepatocellular carcinoma: an indicator for ferroptosis and immune checkpoint inhibitor therapies

A model based on adipose and muscle-related indicators evaluated by CT images for predicting microvascular invasion in HCC patients

Correction to: Hepatic metastatic paraganglioma 12 years after retroperitoneal paraganglioma resection: a case report

Response to Letter Entitled “Re: Anthropometric indicators of adiposity and risk of primary liver cancer: a systematic review and dose-response meta-analysis”

Sex and regional disparities in incidence of hepatocellular carcinoma in autoimmune hepatitis: a systematic review and meta-analysis

Hepatic metastatic paraganglioma 12 years after retroperitoneal paraganglioma resection: a case report

RECK expression is associated with angiogenesis and immunogenic Tumor Microenvironment in Hepatocellular Carcinoma, and is a prognostic factor for better survival

The somatic mutational landscape and role of the ARID1A gene in hepatocellular carcinoma

Anthropometric indicators of adiposity and risk of primary liver cancer: A systematic review and dose–response meta-analysis

Hepatitis B virus reactivation in patients undergoing immune checkpoint inhibition: systematic review with meta-analysis

Suchergebnisse filtern